Deep learning models to predict the editing efficiencies and outcomes of diverse base editors.

Journal: Nature biotechnology
PMID:

Abstract

Applications of base editing are frequently restricted by the requirement for a protospacer adjacent motif (PAM), and selecting the optimal base editor (BE) and single-guide RNA pair (sgRNA) for a given target can be difficult. To select for BEs and sgRNAs without extensive experimental work, we systematically compared the editing windows, outcomes and preferred motifs for seven BEs, including two cytosine BEs, two adenine BEs and three C•G to G•C BEs at thousands of target sequences. We also evaluated nine Cas9 variants that recognize different PAM sequences and developed a deep learning model, DeepCas9variants, for predicting which variants function most efficiently at sites with a given target sequence. We then develop a computational model, DeepBE, that predicts editing efficiencies and outcomes of 63 BEs that were generated by incorporating nine Cas9 variants as nickase domains into the seven BE variants. The predicted median efficiencies of BEs with DeepBE-based design were 2.9- to 20-fold higher than those of rationally designed SpCas9-containing BEs.

Authors

  • Nahye Kim
    Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Sungchul Choi
    Department of Pharmacology, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Sungjae Kim
    Precision Medicine Institute, Macrogen, Seoul, Republic of Korea.
  • Myungjae Song
    Department of Pharmacology, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Jung Hwa Seo
    Department and Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Seonwoo Min
  • Jinman Park
    Department of Pharmacology, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Sung-Rae Cho
    Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Hyongbum Henry Kim
    Department of Pharmacology, Yonsei University College of Medicine, Seoul, Republic of Korea.